Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Kura Oncology, Inc.
Kura Oncology, Inc.
University of Arkansas
Palleon Pharmaceuticals, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
West China Hospital
M.D. Anderson Cancer Center
Alume Biosciences, Inc.
GeoVax, Inc.
Intensity Therapeutics, Inc.
PureTech
BioAtla, Inc.
UNICANCER
Cyteir Therapeutics, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Purple Biotech Ltd.
Compugen Ltd
CytomX Therapeutics
Dana-Farber Cancer Institute
The Netherlands Cancer Institute
Klus Pharma Inc.
Baylor College of Medicine
Genmab
Innate Pharma
Taipei Veterans General Hospital, Taiwan
The University of Texas Health Science Center at San Antonio
Incyte Corporation
Incyte Corporation
Radboud University Medical Center
State University of New York - Upstate Medical University
University of Cincinnati
Radiation Therapy Oncology Group
University of Texas Southwestern Medical Center
Rakuten Medical, Inc.
Brown University
Memorial Sloan Kettering Cancer Center
Tactile Medical
University of Alabama at Birmingham
European Organisation for Research and Treatment of Cancer - EORTC
Spherium Biomed
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Trans Tasman Radiation Oncology Group
Dana-Farber Cancer Institute
Icahn School of Medicine at Mount Sinai
University of Miami
Memorial Sloan Kettering Cancer Center
AHS Cancer Control Alberta
Emory University